Premium
Role of Permanent Pacemakers in the Pharmacologic Therapy of Patients with Reentrant Tachyarrhythmias
Author(s) -
FRIEHLING TED D.,
MARINCHAK ROGER A.,
KOWEY PETER R.
Publication year - 1988
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.1988.tb03931.x
Subject(s) - medicine , service (business) , cardiac pacing , family medicine , cardiology , economy , economics
Improved pacemaker technology has permitted application in more diverse groups of patients. A more recently described subset appears to be those with reentrant tachycardias treatable with antiarrhythmic drugs. Here, pacing offers the ability both to test the efficacy of a drug regimen and to provide adjunctive "fail-safe" therapy for those with episodic breakthrough. With the advent of more sophisticated devices, especially those with cardioversion/defibrillation capability, we anticipate a growing interest in these applications which will undoubtedly benefit patients.